---
title: Acute Coronary Syndromes
layout: diseases
author: Corbin Cox
last-updated: 2018-2-21
created: 2018-2-8
toc: true
common: true
---

# UA vs NSTEMI vs STEMI

|                      | UA               | NSTEMI           | STEMI            |
| -------------------- | ---------------- | ---------------- | ---------------- |
| Pain Duration        | Rest, &gt;20 min | Rest, &gt;20 min | Rest, &gt;20 min |
| Pain Relieved by NTG | Maybe            | No               | No               |
| ST Elevation         | No               | No               | Yes              |
| Q Waves Present      | No               | Uncommon         | Yes              |
| Troponin             | Negative         | Positive         | Positive         |

## Shared Exam Findings

* SSx of Ventricular Dysfunction
* Variable HR
* Elevated RR
* Abnormal Heart Sounds

# Universal Management of ACS

## MONA Therapy

1. Morphine 2-4mg IV q5-30min in increments of 2-8mg PRN
   * BP and RR after each bolus
   * Can consider meperidine or other opiod
   * D/C all NSAIDs and avoid all NSAIDs during admission
2. O<sub>2</sub> to sat of 95% if &lt; 90% on presentation
3. SL NTG 0.4mg q5min x3, if non-responsive start IV NTG 5-10mcg/min to 75-100mcg/min (Max 200, consider 1-2min bolus of 400mcg/min to load)
   * **Verify NO PDEIs w/i 24-36hr**
   * IV Contraindicated w/ SBP &lt; 90; &gt; 30 mmHg change from baseline; Bradycardia or Tachycardia; **Suspected RV Infarction**
   * Monitor BP and HR q2h while on IV
4. ASA 325mg Chewed and Swallowed on presentation
5. Consider anxiolytics to decrease HR and demand
6. Consider Stool Softeners: Constipation and straining w/ BM can lead to subsequent MI

# STEMI

If PCI is available w/i 90min at facility, or the pt can be transferred to a PCI facility w/i 120min, initiate PCI

## PCI Managment

1. PCI w/i 90min
2. DAPT w/ ASA and Clopidogrel, Ticagrelor, or Prasugrel &pm; GPIs
   * Consider GPIs if Other antiplatelets are not used or during bailout for thrombotic complications
3. Anticoagulate w/  UFH or IV Bivalirudin

### Dosing

#### Antiplatelets

* ASA
  * 325mg chewed and swallowed (MONA)
  * 81mg QD forever
* Clopidogrel
  * 600mg before PCI then 75mg QD for at least 1yr
  * D/C 5d before elective CABG
  * D/C 24hr before emergent CABG
* Ticagrelor
  * 180mg before PCI then 90mg BID for at least 12mo
  * **No more than 100mg ASA QD**
  * D/C 5d before elective CABG
  * D/C 24hr before emergent CABG
  * **Contraindicated in Hx of Hemorrhagic Stroke, Ischemic Stroke, PO Anticoagulant Use, Mod-Severe Liver Disease**
  * Reversible inhibitor, so effects are gone 12hr after D/C
* Prasugrel
  * 60mg PO load then 10mg QD (5mg if &le; 60kg) for at least 12mo
  * D/C 7d before elective CABG
  * Extreme caution in pts &ge; 75yo or &le; 60kg
  * **Contraindicated in Hx of Hemorrhagic Stroke, Ischemic Stroke, PO Anticoagulant Use, Mod-Severe Liver Disease**
* Cangrelor
  * 30mcg/kg IVPB then 4mcg/kg/min for 2hr or duration of PCI (whichever is longer)
  * Higher bleeding risk than Clopidogrel
  * Not for use w/ PO P2Y12 Inhibitors or GPI

#### GPIs

* Abciximab
  * 0.25 **mg**/kg bolus then 0.125 **mcg**/kg.min (Max 10) for up to 12hr after PCI
* Eptifibitide
  * 180 mcg/kg/min IV bolus q10min x2 then 2 mcg/kg/min for up to 18hr after PCI
  * 1 mcg/kg/min if CrCl &lt; 50 mL/min
* Tirofiban
  * 25 mcg/kg bolus then 0.15 mcg/kg/min for up to 18hr after PCI
  * Reduce infusion by 50% if CrCl &lt; 30 mL/min

Contraindications

* Active Internal Bleed, major surgery, stroke &lt; 30d
* Hx of Hemorrhagic Stroke
* Intracranial Neoplasm
* AV Malformation
* Acute PEricarditis
* SBP &gt; 180 or DBP &gt; 110
* Plt &lt; 100k

Monitoring

* SSx of Hemorrhage
* CBC: Baseline and QD
* SCr: Baseline and QD
* Plt: Baseline, 2-4hr post initiation, and QD

#### Anticoagulation

**Do not continue after procedure w/o other indication**

* UFH
  * 50-70 U/kg w/ GPI (ACT 250-350s)
  * 70-100 U/kg w/o GPI (ACT 200-250s)
* Enoxaparin
  * 0.5 mg/kg IVPB
* Bivalirudin
  * 0.75 mg/kg IVPB then 1.75 mg/kg/hr until end of PCI, can continue at 0.25 mg/kg/hr if needed
  * No mortality advantage, but lower bleed risk and higher stent thrombosis risk
  * Use if high risk of bleed or HIT
  * Monitor SSx of bleeding; Baseline and QD SCr and CBC; Baseline aPTT, INR, and Plt

### Antiplatelet Selection

* High CV Risk Pts: Prasugrel or Ticagrelor
* Unknown Coronary Anatomy or High Likelihood of CABG: Ticagrelor
* &lt; 60kg, &ge; 75yo, or Hx of TIA: Avoid Prasugrel
* High Bleed Risk: Clopidogrel

## Medical Managment

1. Fibrinolysis w/i 30min (hopefully w/i 12hr of pain onset)
2. DAPT w/ ASA and Clopidogrel
3. Anticoagulate w/ UFH, IV and SC Enoxaparin, or IV and SC Fondaparinux

### Dosing

#### Fibrinolytics

* SK
  * 1.5million U in 50mL D5W or NS over 60min
  * Can cause allergic reactions, hypotension, hemostatic defects, and intracerebral bleeds
  * Do not give to a person more than once in their life
  * **Can only use UFH as anticoagulant, start 3-4hr after beginning of SK**
* tPA
  * 15mg bolus then 0.75mg/kg (Max 50mg) over 30min then 0.5 mg/kg (Max 35mg) over 60min
  * Hemostatic Defect and Intracerebral bleeds
* Reteplase
  * 10 U IVPB then 10 U IVPB 30min later
  * Hemostatic Defect and Intracerebral bleeds
* Tenecteplase
  * &le; 60kg: 30mg IVPB
  * 60-69.9kg: 35mg IVPB
  * 70-79.9kg: 40mg IVPB
  * 80-89.9kg: 45mg IVPB
  * &ge; 90kg: 50mg IVPB
  * Hemostatic Defect and Intracerebral bleeds
* Absolute CIs
  * Hx of Intracranial Hemorrhage
  * Structural Cerebral Vascular Lesion
  * Malignant IC Neoplasm
  * Ischemic Stroke w/i 3mo
  * Active Internal Bleeding
  * Significant Facial Trauma w/i 3mo
  * SK: Past Exposure w/i 6mo
  * Severe HTN refractory to treatment
* Relative CIs
  * Hx Poorly Controlled HTN
  * Hx of Ischemic Stroke
  * Traumatic or Prolonged CPR or Major Surgery (Surgery w/i 3wks)
  * Internal Bleeding (<2-4wks)
  * Pregnancy
  * Active Ulcers
  * Current Anticoagulant Use
  * &gt; 75yo
* Monitoring
  * SSx of Reperfusion
  * SSx of Bleeding
  * CBC: Baseline and QD
  * Plt: Baseline
  * INR/aPTT: Baseline
  * Mental Status Q2H

#### Antiplatelts

* ASA
  * 325mg chewed and swallowed then 81mg QD forever
* Clopidogrel
  * 300mg loading dose then 75mg QD
  * Minimum of 14d, up to 1yr
  * D/C 5d before elective CABG
  * **Do not load if &gt; 75yo**

#### Anticoagulation

Give for at least 48hr, preferably 8d or duration of hospital stay

* UFH
  * 60 U/kg IVPB (Max 4000 U) the 12 U/kg/hr (Max 1000 U/hr)
  * aPTT 50-70s (1.5-2x control)
  * Not for more than 48hr
  * Monitor SSx of Bleeding; Baseline and QD CBC; aPTT Baseline and q6h until stable then QD; Plt Baseline then q1-3d (preferably QD); Baseline INR
* Enoxaparin
  * 30mg IVPB and 1mg/kg SC Q12H (Usually max 100mg for first 2 doses)
  * CrCl [10,30) 1mg/kg SC Q24H
  * &gt; 75yo 0.75 mg/kg Q12H (Max of 75mg for first 2 doses)
  * Monitor SSx of Bleeding; Baseline and QD SCr and CBC; Baseline Plt, aPTT, and INR (Plt only if UFH w/i ~3mo)
* Fondaparinux
  * 2.5mg IVPB then 2.5mg SC QD for up to 8d or until CABG or PCI
  * **Caution if CrCl 30-50 mL/min**
  * **CI if CrCl &lt; 30 mL/min**
  * Monitor SSx of Bleeding; Baseline and QD CBC and SCr; Baseline aPTT, INR, and Plt

## Secondary Prevention

* Non-ISA &beta;-Blockers

  * Metoprolol 25-50mg PO q6h or 5mg IVPB q5min x3 then PO
  * Propranolol 40-80mg PO q6-8hr
  * Atenolol 50-100mg PO QD or 5mg IVPB q5min x2 then PO
  * Carvedilol 25-50mg PO BID
  * Monitoring for PO: BP, HR, RR, 12 lead ECG, and SSx of HF q shift
  * Monitoring for IV: BP, HR, RR, 12 lead ECG, and SSx of HF q5min

* RAAS Inhibitors

  | Drug           | Initial Dose | Target Dose        |
  | -------------- | ------------ | ------------------ |
  | Captopril      | 6.25-12.5 mg | 50mg BID-TID       |
  | Lisinopril     | 2.5-5mg      | 10-20mg QD         |
  | Enalapril      | 2.5-5mg      | 10mg BID           |
  | Ramipril       | 1.25-2.5mg   | 5mg BID or 10mg QD |
  | Trandolapril   | 1mg          | 4mg QD             |
  | Candesartan    | 4-8mg        | 32mg QD            |
  | Valsartan      | 40mg         | 160mg BID          |
  | Losartan       | 12.5-25mg    | 150mg QD           |
  | Eplerenone     | 25mg         | 50mg QD            |
  | Spironolactone | 12.5mg       | 25-50mg QD         |

  * ACEIs to all pts w/ LVEF &lt; 40%, DM or CKD w/o hypotension
  * ACEIs / ARBs CI in Pregnancy, BRAS, hypotension
  * ACEIs CI in previous angioedema
  * Start ACEI or ARB w/i 24hr w/ stable BP
  * **Do not give IV ACEI w/i 24hr of MI**
  * Aldosterone Antagonists should be considered in patients w/ LVEF &lt; 40% w/ HF SSx OR DM
  * Aldosterone Antagonists should be started w/i 3-14d post MI
  * Aldosterone Antagonists should not be used w/ SCr &gt; 2.5 in men or &gt; 2 in women (or CrCl &lt; 30 mL/min), or w/ [K] &gt; 5 or who are receiving a K sparing diuretic
  * Aldosterone Antagonists do not require K supplementation if K &gt; 4
* Appropriate Statin
* Magnesium if low (to prevent hypokalemia)
* Glycemic Control PRN
* DHP CCB if angina is refractory to NTG and &beta;-blockers

# NSTEMI

## Ischemia Strategy vs Early Invasive

Medical therapy unless

* Failure of medical therapy
* High TIMI risk
* Myocardial ischemia on non-invasive test
* Require diagnostic coronary angiography anyway

## TIMI Risk Score for NSTE-ACS

One point for each of the following:

* Age &ge; 65
* &ge; 3 risk factors
  * SSx of HF
  * Low SBP
  * Tachycardia
  * Old Age
  * Elevated SCr
  * Arrest on Admission
  * ST-Deviation
  * Elevated Troponin
* CAD
* &ge; 2 episodes of chest pain in the last 24hr
* &ge; 0.5mm ST-segment depression
* (+) Biochemical Markers

Score Evaluation

* 0-2: Low risk (Can Treat Outpatient)
* 3-4: Medium Risk (Treat Inpatient)
* 5-7: High Risk (Treat Inpatient)

Risk of Events:

* 0-1: 4.6%
* 2: 8.3%
* 3: 13.2%
* 4: 19.9%
* 5: 26.2%
* 6-7: 40.9%

## Ischemia Guided Therapy

1. DAPT w/ ASA and Clopidogrel or Ticagrelor
2. Anticoagulation w/ UFH, SC Enoxaparin, or SC Fondaparinux
3. Secondary Prevention as w/ STEMI

### Dosing

* UFH
  * Same as Fibrinolysis
* Enoxaparin
  * 1 mg/kg SC Q12H w/ typical dose adjustments
* Fondaparinux
  * 2.5mg SC QD for ups to 8d
  * Avoid if CrCl &lt; 30 mL/min

## Early Invasive Therapy

1. DAPT w/ ASA and Clopidogrel and Ticagrelor &pm; GPIs
2. Anticoagulation w/ UFH, SC Enoxaparin, SC Fondaparinux, or IV Bivalirudin
3. Angiography determines PCI, CABG, or medical management

### Dosing

* UFH
  * Same as for PCI
* Enoxaparin
  * 0.3 mg/kg IVPB if last dose was &gt; 8-12hr or if less than 2 doses have been received
  * Treat for 24-48hr or until end of PCI
* Bivalirudin
  * 0.1 mg/kg IVPB followed by 0.25 mg/kg/hr
  * For PCI second bolus of 0.5 mg/kg IVPB followed by 1.75 mg/kg/hr
  * Reduce to 1 mg/kg/hr (CrCl &lt; 30 mL/min) or 1.4 mg/kg/hr (CrCl (30,60))
  * Continue PRN after PCI at 0.25 mg/kg/hr

# Guidelines

* [ACS Guidelines (AHA / ACC)](http://www.acc.org/clinical-topics/acute-coronary-syndromes#sort=%40fwhatstrendingscore86069%20descending&tab=guidelines)
* [PCI in STEMI](http://www.onlinejacc.org/content/67/10/1235)
* [STEMI Management](http://www.onlinejacc.org/content/61/4/e78)
* [NSTEMI Management](http://circ.ahajournals.org/content/130/25/e344)
* [DAPT in ACS](http://www.onlinejacc.org/content/68/10/1082)
